Development and exploration of an AI model to classify "healthy subject" and "suspected schizophrenia patient" based on free conversations with medical staff

Sumitomo Dainippon Pharma Co., Ltd.0 个研究点目标入组 150 人开始时间: 2021年12月8日最近更新: 2022年5月28日

适应症

试验速览

暂无简介。

•Schizophrenia
•Between 18 and 65 years of age at the time of consent and diagnosed with schizophrenia according to the DSM-
•Healthy Subject
•Between the ages of 18 and 65 years old at the time of consent.
•2) in Common
•Who speak Japanese as his/her mother tongue and able to have an interview (conversation with doctors and medical staff)
•Who can obtain written consent from the person and also his / her substitute if the subject is under 20 years old.

•Who has been judged by a doctor to have difficulty in having conversation due to deafness, dysarthria, aphasia, etc.
•Who has been diagnosed of having a pyschiatric disorder such as depression
•Who has been diagnosed of a dementia or judged to have cognitive dysfunction due to neurological diseases (epilepsy, stroke, etc.)
•Who has been judged by a doctor not to be suitable for this trial by any reasons

classify healthy subject and suspected schizophrenia patient

to classify "healthy subject" and "suspected schizophrenia patient"

classify history of hospitalization for schizophrenic patient

to classify the history of hospitalization for schizophrenic patient

未报告次要终点

发起方